Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entecavir Retreatment in Chronic Hepatitis B
NCT01438424Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jan 2001
- Primary completion
- Dec 2009
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of entecavir in Chronic Hepatitis B (CHB), sponsored by Bristol Myers Squibb. Started Jan 2001; status: completed.
02
Drugs
entecavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01438424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01438424.